Cargando…

Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989

BACKGROUND: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. METHODS: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989–2006 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeven, R H A, Louwman, W J, Koldewijn, E L, Demeyere, T B J, Coebergh, J W W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990603/
https://www.ncbi.nlm.nih.gov/pubmed/20877361
http://dx.doi.org/10.1038/sj.bjc.6605914
_version_ 1782192487690928128
author Verhoeven, R H A
Louwman, W J
Koldewijn, E L
Demeyere, T B J
Coebergh, J W W
author_facet Verhoeven, R H A
Louwman, W J
Koldewijn, E L
Demeyere, T B J
Coebergh, J W W
author_sort Verhoeven, R H A
collection PubMed
description BACKGROUND: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. METHODS: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989–2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. RESULTS: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. CONCLUSION: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers.
format Text
id pubmed-2990603
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-29906032011-10-26 Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989 Verhoeven, R H A Louwman, W J Koldewijn, E L Demeyere, T B J Coebergh, J W W Br J Cancer Epidemiology BACKGROUND: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. METHODS: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989–2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. RESULTS: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. CONCLUSION: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers. Nature Publishing Group 2010-10-26 2010-09-28 /pmc/articles/PMC2990603/ /pubmed/20877361 http://dx.doi.org/10.1038/sj.bjc.6605914 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Verhoeven, R H A
Louwman, W J
Koldewijn, E L
Demeyere, T B J
Coebergh, J W W
Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
title Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
title_full Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
title_fullStr Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
title_full_unstemmed Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
title_short Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989
title_sort scrotal cancer: incidence, survival and second primary tumours in the netherlands since 1989
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990603/
https://www.ncbi.nlm.nih.gov/pubmed/20877361
http://dx.doi.org/10.1038/sj.bjc.6605914
work_keys_str_mv AT verhoevenrha scrotalcancerincidencesurvivalandsecondprimarytumoursinthenetherlandssince1989
AT louwmanwj scrotalcancerincidencesurvivalandsecondprimarytumoursinthenetherlandssince1989
AT koldewijnel scrotalcancerincidencesurvivalandsecondprimarytumoursinthenetherlandssince1989
AT demeyeretbj scrotalcancerincidencesurvivalandsecondprimarytumoursinthenetherlandssince1989
AT coeberghjww scrotalcancerincidencesurvivalandsecondprimarytumoursinthenetherlandssince1989